2-(2-((3-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

4-Benzenesulfonylbenzoic acid, 95.0%, 250mg

(S)-1-N-Boc-3-Cyano-pyrrolidine, 95.0%, 10g

1-((tert-Butyldimethylsilyl)oxy)propan-2-one, 95.0%, 100g

2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 25g

Reagent reservoirs 175 ml with lid, Non sterile, 10 x 10, 100 pieces

cyclopropyl(1-methyl-1H-1,2,4-triazol-5-yl)methanone, 95.0%, 5g

5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylic acid, 95.0%, 250mg

3-Ethylbenzaldehyde, 95.0%, 5g

3,6,9,12,15,18,21-Heptaoxatricosanedioic acid, 97%, 5g

trans-1-Benzyl-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid, 97%, 1g

5-Bromo-2-chloro-6-methylpyridin-3-amine, 97.0%, 10g

14-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)-3,6,9,12-TETRAOXATETRADECANOIC ACID, 95%, 250mg